2016 – a great year for SpermVital

All signs are pointing in the right direction for SpermVital.

Publisert 10. mars 2017
Revidert 27. oktober 2020
Skrevet av brit
2016 – a great year for SpermVital
Fotokred_hvit Rakel J. Berg
SpermVital har patentert og kommersialisert en ny teknologi for kunstig sædoverføring

In 2016 the company secured deals with three new breeding companies, while increasing their turn-over by 44% compared to 2015. The company was valuated by DHT Corporate Services to 238 mNOK – more than a doubling since the last valuation in 2011.

According to CEO Nils Chr. Steig, this positive development can be attributed to a targeted market effort: ‘We see that the SpermVital proprietary technology receives a lot of positive attention, however –  this is a conservative industry that is accustomed to making decisions based on solid evidence and quality-assured information’. He also adds that in the past five years, SpermVital has grown significantly and that today the company is lucky to have 20 highly competent and dedicated employees.

Meld deg på vårt nyhetsbrev

Hold deg oppdatert på aktiviteter i klynga.

NCE Heidner Biocluster

NCE Heidner Biocluster
Holsetgata 22
2317 Hamar

Innlandet Fylkeskommune Innovasjon Norge Cluster management


Klosser Innovasjon

2020 © NCE Heidner Biocluster | Dette nettstedet bruker cookies. Se vår personvernerklæring | Utviklet av Dialecta kommunikasjon AS